stockrow
Friday 6 November 2026
Export ADUS’s income statement to Excel — free account
Addus HomeCare Corporation
ADUS Healthcare Medical Care Facilities
Addus HomeCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 23.2% from fiscal 2024.
- Revenue
- +7.02%
- EPS
- +24.2%
- Free cash flow
- −17.1%
- Total debt
- −85.4%
Quarter to September 2026, against a year earlier
124.79
2.02
−1.59%
Follow ADUS
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
20.61 | 17.31 | 17.63 | 18.42 |
P/S ratio |
1.36 | 1.18 | 1.24 | 1.35 | |
P/FCF ratio |
18.70 | 12.41 | 11.88 | 14.02 | |
P/Operating CF |
103.33 | 32.54 | 45.93 | 49.42 | |
P/B ratio |
1.79 | 1.53 | 1.60 | 1.76 | |
Price to Tangible BV |
0.00 | 89.72 | 45.15 | 47.42 | |
EV/Sales |
1.39 | 1.17 | 1.22 | 1.30 | |
EV/EBITDA |
12.66 | 10.58 | 10.83 | 11.26 | |
EV/Operating CF |
17.75 | 11.68 | 11.09 | 12.80 | |
EV/FCF |
19.09 | 12.33 | 11.64 | 13.49 | |
Quick Ratio |
1.56 | 1.66 | 1.46 | 1.51 | |
Current Ratio |
1.80 | 1.83 | 1.69 | 1.64 | |
Net Debt/EBITDA |
0.84 | (0.31) | (0.87) | 0.00 | |
Debt/Assets |
8.42% | 6.36% | 4.23% | 1.51% | |
Debt/Equity |
0.11 | 0.08 | 0.05 | 0.02 | |
Asset Turnover |
1.00 | 1.02 | 1.03 | 1.05 | |
Operating CF/Net income |
0.63 | 2.09 | 1.45 | 1.43 | |
Capex/Depreciation |
(0.59) | (0.39) | (0.30) | (0.45) | |
Interest Coverage |
15.51 | 15.84 | 22.59 | 58.73 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
20.69% | 21.39% | 20.80% | 20.75% | |
Intangible Assets out of Total Assets |
0.76 | 0.76 | 0.76 | 0.76 | |
Share Based Compensation of Revenue |
1.22% | 1.38% | 1.16% | 0.00% | |
Graham Net Nets |
(0.04) | (0.03) | (0.01) | 0.01 | |
Graham Number |
83.95 | 86.42 | 89.72 | 0.00 | |
Earnings Yield |
4.85% | 5.78% | 5.67% | 5.43% | |
Free Cash Flow Yield |
5.35% | 8.06% | 8.42% | 7.13% | |
Revenue per Share |
20.67 | 19.99 | 20.63 | 0.00 | |
Operating CF per Share |
1.04 | 2.88 | 2.19 | 0.00 | |
Capex per Share |
(0.15) | (0.09) | (0.07) | (0.11) | |
Free Cash Flow per Share |
0.89 | 2.79 | 2.12 | 0.00 | |
Cash per Share |
4.52 | 5.66 | 5.44 | 0.00 | |
Shareholders Equity per Share |
60.12 | 61.35 | 62.77 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
60.12 | 61.35 | 62.77 | 0.00 | |
Free Cash Flow |
16.11 | 50.67 | 38.69 | 40.91 | |
Working Capital |
120.00 | 123.40 | 116.00 | 109.78 | |
Capital Expenditures |
(2.66) | (1.69) | (1.32) | (1.99) | |
Net Current Asset Value |
(82.51) | (46.66) | (24.18) | 10.80 | |
EV/EBIT |
14.28 | 11.91 | 12.15 | 12.55 | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
13.99 | 11.98 | 12.40 | 13.04 | |
| Other line items | |||||
Average Receivables |
137.29 | 139.72 | 142.61 | 147.46 | |
Average Payables |
22.00 | 21.00 | 16.86 | 18.40 | |
Average Assets |
1,424.97 | 1,421.64 | 1,432.71 | 1,436.56 | |
Average Common Equity |
1,027.90 | 1,055.77 | 1,085.01 | 1,114.87 |
Columns are period end dates · fundamentals updated 5 Nov 2026